Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 98321

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
January 21, 2026
Product types
Drug
Classifications
Class III
Statuses
Ongoing
Recalling firm wording
Unichem Pharmaceuticals USA Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

D-0306-2026
Recall number
D-0306-2026
Initiated
January 21, 2026
Classification
Class III
Status
Ongoing
Quantity
60,000 tablets

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Tablets/Capsules Imprinted with Wrong ID

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Tablets/Capsules Imprinted with Wrong ID

Code information

Lot # GDSH25006, Exp Date: 08/2027

Distribution pattern

Nationwide